FDA Drug Approval, N019422, EXIDINE
FDA Drug Approval, N019422, EXIDINE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 019422
Company: XTTRIUM
Drug Name: EXIDINE
Active Ingredients: CHLORHEXIDINE GLUCONATE
Strength: 2%
Dosage Form/Route: SOLUTION;TOPICAL
Action Date: 12/17/1985
Marketing Status: Over-the-counter
Submission Classification: Type 3 - New Dosage Form
Company: XTTRIUM
Drug Name: EXIDINE
Active Ingredients: CHLORHEXIDINE GLUCONATE
Strength: 2%
Dosage Form/Route: SOLUTION;TOPICAL
Action Date: 12/17/1985
Marketing Status: Over-the-counter
Submission Classification: Type 3 - New Dosage Form
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details